Estrella Immunopharma Quote - ESLA

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.1723

Bid

1.10

Offer

1.17

Volume

1,354

1.0361 Day's Range 1.1723

0.63 52 Week Range 3.23

Market Cap

42.413M

Previous Close

1.11

Open

1.10

Last Trade

1.16

Last Trade Time

Financial Volume

US$ 1,420

VWAP

1.0485

Average Volume (3m)

30,928

Shares Outstanding

36,179,147

Dividend Yield

PE Ratio

-5.79

Earnings Per Share (EPS)

-0.2

Revenue

Net Profit

-7.31M

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Headquarters

Wilmington, Delaware, USA

Founded

Estrella Immunopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ESLA. The last closing price for Estrella Immunopharma was US$1.11. Over the last year, Estrella Immunopharma shares have traded in a share price range of US$ 0.63 to US$ 3.23.

Estrella Immunopharma currently has 36,179,147 shares in issue. The market capitalisation of Estrella Immunopharma is US$40.16 million. Estrella Immunopharma has a price to earnings ratio (PE ratio) of -5.79.

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0523	4.66964285714	1.12	1.19	1.06	8647	1.13452051	CS
4	-0.0277	-2.30833333333	1.2	1.3165	1.02	11996	1.17550312	CS
12	0.3223	37.9176470588	0.85	1.485	0.695101	30928	1.19669268	CS
26	-1.0977	-48.3568281938	2.27	2.55	0.63	83844	1.20285262	CS
52	-0.0477	-3.90983606557	1.22	3.23	0.63	70298	1.42057076	CS
156	-4.0377	-77.4990403071	5.21	5.62	0.63	73569	1.5541104	CS
260	-4.0377	-77.4990403071	5.21	5.62	0.63	73569	1.5541104	CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?

The current share price of Estrella Immunopharma is US$ 1.1723

How many Estrella Immunopharma shares are in issue?

Estrella Immunopharma has 36,179,147 shares in issue

What is the market cap of Estrella Immunopharma?

The market capitalisation of Estrella Immunopharma is USD 40.16M

What is the 1 year trading range for Estrella Immunopharma share price?

Estrella Immunopharma has traded in the range of US$ 0.63 to US$ 3.23 during the past year

What is the PE ratio of Estrella Immunopharma?

The price to earnings ratio of Estrella Immunopharma is -5.79

What is the reporting currency for Estrella Immunopharma?

Estrella Immunopharma reports financial results in USD

What is the latest annual profit for Estrella Immunopharma?

The latest annual profit of Estrella Immunopharma is USD -7.31M

What is the registered address of Estrella Immunopharma?

The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801

Which industry sector does Estrella Immunopharma operate in?

Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DGNXDiginex Ltd	US$ 49.18 (228.09%)	3.34M
SLXNSilexion Therapeutics Corporation	US$ 3.1301 (131.86%)	330.45M
KRKR36Kr Holdings Inc	US$ 9.10 (114.12%)	23.61M
SPGCSacks Parente Golf Inc	US$ 0.6001 (57.92%)	52.17M
XFORX4 Pharmaceuticals Inc	US$ 0.7542 (56.54%)	42.5M
ZKINZK International Group Co Ltd	US$ 0.4813 (-41.21%)	3.1M
MGOLMGO Global Inc	US$ 0.1019 (-38.73%)	70.52M
BACKIMAC Holdings Inc	US$ 0.7869 (-35.50%)	2.37M
EYENEyenovia Inc	US$ 0.03695 (-35.18%)	25.31M
HAOHaoxi Health Technology Ltd	US$ 2.52 (-31.89%)	484.94k
NVDANVIDIA Corporation	US$ 123.70 (-4.10%)	466.94M
SLXNSilexion Therapeutics Corporation	US$ 3.1301 (131.86%)	330.45M
OCEAOcean Biomedical Inc	US$ 0.249929 (-24.26%)	186.52M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.428 (-6.98%)	148.12M
RIMEAlgorhythm Holdings Inc	US$ 0.0259 (-16.18%)	138.96M